Cleared Abbreviated

K160439 - SunTech CT40 Spot-check Vital Signs Device

K160439 is the FDA 510(k) clearance for SunTech CT40 Spot-check Vital Signs Device by Suntech Medical. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Abbreviated 510(k) pathway after a 140-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
140d
Days
Class 2
Risk

K160439 is an FDA 510(k) clearance for the SunTech CT40 Spot-check Vital Signs Device. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Suntech Medical (Morrisville, US). The FDA issued a Cleared decision on July 6, 2016 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Suntech Medical devices

Submission Details

510(k) Number K160439 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 2016
Decision Date July 06, 2016
Days to Decision 140 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d slower than avg
Panel avg: 125d · This submission: 140d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K160439.
Full Automatic (NIBP) Blood Pressure Monitor
K162338 · Health & Life Co., Ltd. · Sep 2016
Fully Automatic Electronic Blood Pressure Monitor
K160565 · Andon Health Co, Ltd. · Aug 2016
Fully Automatic Electronic Blood Pressure Monitor
K160563 · Andon Health Co, Ltd. · Aug 2016
Full Automatic (NIBP) Blood Pressure Monitor
K160557 · Health & Life Co., Ltd. · Jul 2016
Full Automatic (NIBP) Blood Pressure Monitor
K161156 · Health & Life Co., Ltd. · Jun 2016
EV1000 Clinical Platform with ClearSight Finger Cuff or ClearSight System, EV1000 Clinical Platform
K160552 · Edwards Lifesciences, LLC · Jun 2016